TUESDAY, June 14, 2022 (HealthDay News) — The first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot, the agency said in aContinue Reading

TUESDAY, June 14, 2022 (HealthDay News) — One person has died and 27 people have been hospitalized in a multi-state salmonella outbreak linked to backyard poultry, the U.S. Centers for Disease Control and Prevention says. Even if they appear healthy and clean, backyard poultry such as chickens can carry salmonella.Continue Reading

Stress can age, weaken your immune system. New research shows that traumatic events, job strain, daily stressors and discrimination may all speed aging of the immune system, raising the risk for cancer, heart disease and other illnesses, including COVID-19. Read more FDA approves first pill to fight severe alopecia. BaricitinibContinue Reading

MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading